C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2001
10/31/2001	CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/31/2001	CN1073799C Use of 2-aryl-1-(akoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles.
10/30/2001	US6310254 Reducing an optically active amino acid with hydrogen in the presence of a ruthenium-containing catalyst and an organic or inorganic acid other than said optically active amino acid to obtain optically active amino alcohol
10/30/2001	US6310217 Antiinflammatory and analgesic agents
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001	CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/28/2001	CA2345846A1 Preparation process for n,n'-carbonylbis-lactams
10/25/2001	WO2001079329A1 Oligo/polysuccinimides, process for producing thereof and their use
10/25/2001	WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001	WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001	WO2001079159A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDES
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001	US20010034364 Isoprenoid pathway inhibitors for stimulating bone growth
10/25/2001	US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001	US20010034344 Use of known agonists of the central cannabinoid receptor CB1
10/25/2001	US20010034341 Bactericides
10/25/2001	US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001	CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2403563A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amides
10/24/2001	EP1148050A1 Retroviral protease inhibitors
10/24/2001	EP1148049A1 Crystalline R-(R,R)$-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl -1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP0848704B1 Form iii crystalline [r-(r,r)]-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
10/24/2001	CN1319086A Anthranilic acid derivatives
10/24/2001	CN1318541A Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application
10/24/2001	CN1073559C Method for preparing chloro-ethyl pyrrolidone
10/24/2001	CN1073551C Ethenyl amide compound prodn process
10/23/2001	US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307059 Preparation of quinolone antibiotics.
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307011 Recovering polar organic solvent from recycle mixture
10/23/2001	US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306873 Substituted β-thiocarboxylic acids
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001	US6306850 Chlorocyclopropyl-3-(2-chlorophenyl)-2-hydroxypropyl)2,4-dihyd ro-(1,2,4)-triazole-3-thione as fungicides
10/23/2001	CA2085570C Pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them
10/23/2001	CA2035397C Hexahydropyrrolo¬2,3-b\|indole carbamates, -ureas, -amides and related compounds, a process for their preparation and their use as medicaments
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077091A2 Ns5b hcv polymerase inhibitors
10/18/2001	WO2001077073A1 Cathepsin cysteine protease inhibitors
10/18/2001	WO2001076596A1 Medicine for treating traumatic brain injury and other neuronal disorders
10/18/2001	US20010031890 Process for the racemization of nu-acylamino acids by means of transition metal catalysts
10/18/2001	US20010031879 Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them
10/18/2001	US20010031780 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv)
10/18/2001	CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001	CA2404630A1 Cathepsin cysteine protease inhibitors
10/17/2001	EP1146039A2 Porphobilinogen derivative and method to produce the same
10/17/2001	EP1144370A2 Thyroid receptor ligands
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144366A2 Use of androgen receptor suppressors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144360A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143951A2 Antimalarial agents
10/17/2001	EP0942911B1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
10/17/2001	EP0709373B1 Pyrrolidine derivative
10/17/2001	CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity
10/17/2001	CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001	CN1318054A Novel compounds
10/17/2001	CN1318052A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers
10/17/2001	CN1073111C Process for preparation of 2,3-pyridinedicarboximides
10/16/2001	US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001	US6303611 For therapy of hyperalgesis
10/16/2001	US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001	US6303312 Modifying cell phenotype; medical research and therapy
10/16/2001	CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same
10/11/2001	WO2001074950A2 Mono- and bis-hydrazone pigments
10/11/2001	WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001	WO2001074772A1 Chemokine receptor antagonists
10/11/2001	WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes
10/11/2001	WO2001074770A1 C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2001	WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001	WO2001074762A2 Arylsulfates and their use as enhancers or inhibitors of bioadhesion to surfaces
10/11/2001	WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001	WO2001074180A1 Nutritional supplements for stimulating bone growth
10/11/2001	WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001	WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
10/11/2001	WO2000016763A3 Antimalarial agents
10/11/2001	DE10016544A1 New phenyl-substituted cyclic keto-enol compounds useful e.g. as insecticides, acaricides, nematocides, acaricides, herbicides, ectoparasiticides, antifouling agents or intermediates
10/11/2001	DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001	CA2829534A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001	CA2404868A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001	CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001	CA2404312A1 Chemokine receptor antagonists
10/11/2001	CA2403328A1 Mono- and bis-hydrazone pigments
10/11/2001	CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001	EP1142872A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/10/2001	EP1142868A1 Amide derivatives
10/10/2001	EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 404